Skip to content

BD BBL™ TB Carbolfuchsin KF 212518Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ TB Carbolfuchsin KF, 250 mL · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 30382902125182), received between Apr 9, 2021 and Jan 7, 2025 — classified as 7 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (6 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 3 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings6
  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Clinical Signs, Symptoms or Conditions7

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 7, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 1 OF 3: IT WAS REPORTED WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF, NOCARDIA STAINED AS FULL ACID FAST ON A PATIENT SAMPLE. A PRELIMINARY RESULT WAS REPORTED AS AN ACID-FAST ORGANISM, AND THEN UPON FURTHER REVIEW RESULTS WERE CORRECTED. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21098659 ↗
  • MalfunctionJan 7, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 2 OF 3: IT WAS REPORTED WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF, NOCARDIA STAINED AS FULL ACID FAST ON A PATIENT SAMPLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21098657 ↗
  • MalfunctionJan 7, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 3 OF 3: IT WAS REPORTED WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF, NOCARDIA STAINED AS FULL ACID FAST ON A PATIENT SAMPLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21098656 ↗
  • MalfunctionFeb 16, 2022Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    IT WAS REPORTED WHILE TESTING WITH BD BBL¿ TB CARBOLFUCHSIN KF PRECIPITATE AND IMPURITIES WERE FOUND IN THE STAIN. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IMPURITES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13545001 ↗
  • MalfunctionJun 18, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "IMPURITIES".

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12028646 ↗
  • MalfunctionApr 12, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF CONTAMINATION PRECIPITATE WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. "IMPURITY. ON 21MAR2021/(B)(4). UPDATE FROM RCC PROVIDED: THERE IS NO CONTAMINATION. YES, IT IS PRECIPITATE IN THE STAIN. USER FOUND THE PURPLE PARTICLE AFTER LOOKING AT THE MICROSCOPE."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11653760 ↗
  • MalfunctionApr 9, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF CONTAMINATION PRECIPITATE WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: " IMPURITY: (B)(6) - UPDATE FROM (B)(6) : THERE IS NO CONTAMINATION. YES, IT IS PRECIPITATE IN THE STAIN. YOU CAN ALSO FIND THE PURPLE PARTICLE IN THE MICROSCOPE PHOTO AS (B)(6) ATTACHED. USER FOUND THE PURPLE PARTICLE AFTER LOOKING AT THE MICROSCOPE. PURPLE PARTICLE COVERED THE STAIN RESULTS. IT INCREASES THE ERROR RISK OF CLINICAL REPORT."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11644614 ↗

Other CARBOL FUCHSIN devices

All CARBOL FUCHSIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page